Published in Medicine and Law Weekly, January 20th, 2006
These candidate genes were discovered using Alethia's proprietary STAR technology (Subtractive Transcription-based Amplification of mRNA), a unique, patented discovery platform developed by scientists at Alethia to identify key regulators of biological activity in diseased cells and tissues.
These new targets represent a diverse collection of highly specific regulators...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly